Results 61 to 70 of about 29,949 (204)

Enoxaparin-Associated Dermal Necrosis: A Consequence of Cross-Reactivity with Heparin-Mediated Antibodies

, 1997
Objective To describe a patient with enoxaparin-induced dermal necrosis and to review previously reported cases of skin manifestations associated with low-molecular-weight heparins.
Robyn A Schaiff, Marin H Kollef, Michael E Tonn   +2 more
core   +1 more source

Intermittent pneumatic compression versus additional prophylaxis with enoxaparin for prevention of venous thromboembolism after laparoscopic surgery for gastric and colorectal malignancies: multicentre randomized clinical trial

BJS Open, 2020
Background The role of antithrombotic chemoprophylaxis in prevention of venous thromboembolism (VTE) in laparoscopic surgery for gastric and colorectal malignancies is unknown.
H. Kamachi, S. Homma, H. Kawamura, T. Yoshida, Y. Ohno, N. Ichikawa, R. Yokota, T. Funakoshi, Y. Maeda, N. Takahashi, T. Amano, A. Taketomi   +11 more
doaj   +1 more source

International Delphi consensus on feminising genital surgery in assigned‐male‐at‐birth individuals

BJU International, EarlyView.
Objective To achieve an international expert consensus among surgeons on the indications, contraindications, and perioperative management of feminising genital surgery (FGS) for assigned‐male‐at‐birth (AMAB) individuals, using a Delphi process. Methods A two‐round on‐line Delphi survey (May–July 2025) followed by a final consensus meeting (September ...
Marta Pezzoli, Mattia Lo Re, Valeria Pizziconi, Marco Falcone, Mirko Preto, Marco Capece, Michele Rizzo, Guglielmo Mantica, Francesco Chierigo, Malte Vetterlein, Patrizio Vicini, François‐Xavier Madec, Paul Neuville, Wai Gin (Don) Lee, Francesca Vedovo, Saskia Morgenstern, Marjan Waterloos, Miroslav Djordjevic, Wesley Verla, Lukasz Bialek, Juan Diego Tinajero, Jordán Scherñuk, Tim Ludwig, Silke Riechardt, Lisa Szyper, Maren Wenk, Jochen Heß, Julia Bohr, Andrea Minervini, Andrea Cocci, on behalf of the Italian Society of Urodynamics (SIUD)   +30 more
wiley   +1 more source

Anti-Factor Xa Level Monitoring for Enoxaparin Prophylaxis and Treatment in High-Risk Patient Groups

, 2023
Description Monitoring anti-factor Xa levels is a controversial topic in the inpatient setting due to resource utilization and unclear conditional guideline recommendations regarding this practice.
Imboywa, Selina, Antigua, Abigail, Rima Patel, Lucie Sikes, Kipson Charles, Charles, Kipson, Pheba Cherian, Abigail Antigua, Cherian, Pheba, Sikes, Lucie, Patel, Rima, Selina Imboywa   +11 more
core   +1 more source

Prophylactic and therapeutic enoxaparin through pregnancy: indications, outcomes and monitoring.

, 2003
OBJECTIVES: To evaluate the efficacy and safety of prophylactic and therapeutic enoxaparin in pregnancy. STUDY DESIGN: Three-year prospective audit. SETTING: Tertiary level obstetric hospital.
McLintock, C, Rowan, J, Taylor, Rennae, North, Robyn   +3 more
core   +2 more sources

Assessment of Thrombin Generation in Pediatric Patients on Extracorporeal Life Support: Impact of Bivalirudin and Other Anticoagulants

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction Bivalirudin is an alternative anticoagulant to heparin and is widely used in pediatric extracorporeal life support (ECLS). Its activity is monitored using activated partial thromboplastin time (aPTT) and/or more specific tests such as plasma‐diluted thrombin time (dTT).
Vadim Kostousov, Karen Bruzdoski, Amir Navaei, Jun Teruya   +3 more
wiley   +1 more source

Tigecycline combination therapy for fulminant Clostridioides difficile infection: an Australian experience

Internal Medicine Journal, EarlyView.
Abstract Background Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous tigecycline in patients who are progressing to fulminant infection.
Emma Bishop, Tanya Ravipati, Steven Mileto, Eugene Athan, Dena Lyras, Ravindranath Tiruvoipati   +5 more
wiley   +1 more source

Fred J Boyd 2025 oration

Journal of Pharmacy Practice and Research, EarlyView.
Michael Barras
wiley   +1 more source

Retrospective evaluation of outcomes in dogs with non‐associative immune‐mediated haemolytic anaemia treated with rivaroxaban as a sole or adjunctive thromboprophylaxis agent: 34 cases (2018‐2024)

Journal of Small Animal Practice, EarlyView.
Objectives To describe clinical outcomes, thromboembolic and haemorrhagic complications, and treatment characteristics in dogs with non‐associative immune‐mediated haemolytic anaemia treated with rivaroxaban at a UK referral hospital. Materials and Methods Retrospective descriptive study of dogs diagnosed with non‐associative immune‐mediated haemolytic
S. Conway, L. Jenkins, J. Reeve
wiley   +1 more source

Utilization profile of enoxaparin in hospitalized patients with Chronic Kidney Disease in southern Brazil

Brazilian Journal of Pharmaceutical Sciences, 2020
Chronic Kidney Disease (CKD) patients usually require the use of anticoagulants for treatment or prevention of thromboembolic diseases. One such commonly used anticoagulant is enoxaparin. However, special attention is advised when using this drug for CKD
Carolina Araujo Cirne, Tatiane Araujo Castro Machado   +1 more
doaj   +1 more source